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Nuclear magnetic resonance spectroscopy
Sodium allosteric bindingThe melanocortin receptors (MCRs) are members of the G protein-coupled receptor (GPCR) 1 superfamily with
seven transmembrane (TM) domains. Among them, the melanocortin-4 receptor (MC4R) subtype has been
highlighted recently by genetic studies in obese humans. In particular, in a patient with severe early-onset
obesity, a novel heterozygous mutation in the MC4R gene was found in an exchange of Asp to Asn in the 90th
amino acid residue located in the TM 2 domain (MC4RD90N). Mutations in the MC4R gene are the most frequent
monogenic causes of severe obesity and are described as heterozygous with loss of function. We determine
solution structures of the TM 2 domain of MC4R (MC4RTM2) and compared secondary structure of Asp90
mutant (MC4RTM2-D90N) in a micelle environment by nuclear magnetic resonance (NMR) spectroscopy. NMR
structure shows that MC4RTM2 forms a long α-helix with a kink at Gly98. Interestingly, the structure of
MC4RTM2-D90N is similar to that of MC4RTM2 based on data from CD and NMR spectrum. However, the thermal
stability and homogeneity of MC4RD90N is quite different from those of MC4R. The structure from molecular
modeling suggests that Asp902.50 plays a key role in allosteric sodium ion binding. Our data suggest that the
sodium ion interaction of Asp902.50 in the allosteric pocket of MC4R is essential to its function, explaining the
loss of function of the MC4RD90N mutant.
© 2015 Elsevier B.V. All rights reserved.1. Introduction
G-protein-coupled receptors (GPCRs) are the largest and most
diverse family of membrane proteins in eukaryotes, which regulate
diverse biological and physiological processes through orthosteric and
allosteric ligand interaction. The melanocortin receptor (MCR) system
consists of ﬁve receptor subtypes (MC1R–MC5R) and belongs to the
superfamily of Class A GPCRs. The MCRs play an important role in
skin pigmentation [1], adrenocortical function [1], energy homeostasis
[2,3], feeding behavior [4,5], sexual function [6], and exocrine gland
function. The MC4R, expressed predominantly in the brain, has been
considered as an obesity drug target [7,8]. It is activated by agonistsumanmelanocortin 4 receptor;
gnetic resonance; NOE, nuclear
try, College of Life Science and
chon-dong 134, Seoul 120-749,
2706.such as proopiomelanocortin (POMC)-derived peptides and coupled
to the Gs protein and adenylyl cyclase to negatively regulate food intake
[6,9]. In general, heterozygous and homozygous mutants of GPCR are
involved in a loss of function in terms of Gs/adenylyl cyclase activation
and intracellular retention by GPCR mutants. Recently, a number of re-
ports have demonstrated that heterozygous and homozygousmutation
of MC4R is a critical factor in the regulation of food uptake as well as
obesity [5,10–13].
Various homozygous and heterozygousmutants of MC4R have been
identiﬁed: null mutants, intracellular trapped mutants, binding-
defective mutants, and signaling-defective mutants [10,14–18].
Among them, the heterozygous D90N mutant of MC4R (MC4RD90N)
has been identiﬁed as a signaling-defective mutant, which is expressed
on the cell surface with normal ligand binding afﬁnity. Asp90 residue in
the transmembrane (TM) 2 domain of MC4R (MC4RTM2) is highly
conserved in all MCRs, and its mutation induces hetero-dimerization
with wild-type MC4R, blocking MC4R–G protein interaction. Asp90
residue of MC4RTM2 (Asp902.50) is mostly conserved in numerous
Class A GPCRs by the Ballesteros–Weinstein numbering method [19].
Previous mutagenesis studies have reported that the mutation of
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[20–24]. The TM 2 domain is especially important for the stability of
the seven TM domains to regulate its function and agonistic metal ion
binding [16,25]. Despite its biological importance, the structure-
function relationship of the Asp90 mutation is unknown.
A recent report demonstrated that sodium ions participate in allosteric
modulation, bound to the highly conserved Asp residue in the TM 2
domain (Asp2.50) [26], which serves as a heterozygous mutational
site of MC4R. Here, we propose the structural properties of the TM
2 domain of MC4R, which are critical to its function. The solution
structures of both MC4RTM2 and the mutant are determined by circular
dichroism (CD) and nuclearmagnetic resonance (NMR) spectroscopy in
a membrane environment. Moreover, data from analytical size-
exclusion gel chromatography (aSEC) onMC4R andMC4RD90N strongly
support the notion that the conformational transition of MC4R differs
depending on the salt concentration, implying that Asp90 is a key
residue that maintains the functional conformation of MC4R by sodium
ion interaction.
2. Materials and methods
2.1. Cloning, puriﬁcation, and NMR sample preparation of MC4RTM2 and
MC4RTM2-D90N
A 5′-primer, including a DNA sequence-encoding thrombin cleavage
site (LVPRGS) for removing the N-terminal His-tag from the target pro-
tein, and a 3′-primer, including a DNA sequence-encoding soluble KSI
peptide (GGKKKK), were designed. DNA fragments encoding the highly
conserved TM 2 domain of the melanocortin 4 receptor (MC4RTM2)
(Fig. 1A) were cloned into the plasmid pET21b (Promega) for co-Fig. 1. Sequence alignment of MCRs and secondary structure analysis of MC4RTM2 by CD spectro
MC4R were displayed. The MCRs are seven well-known TM GPCR families. All TM regions amo
domain is well conserved among the ﬁve human MCRs. The secondary structure of MC4RTM2
and (C) in different pH values from pH 4.0 to 8.0.expression with the hexa-histidine tag in the N-terminus. MC4RTM2
was overexpressed in the Escherichia coli BL21 (DE3) strain (Novagen).
Optical density in cell growth was measured up to 0.6 at 600 nm
(OD600), and 1 mM isopropyl-1-thio-β-D-galactopyranoside (IPTG)
was used as an inducer of protein overexpression. Cells were over-
cultured for 15 h at 25 °C and harvested by centrifugation (6000 rpm,
30 min).
The cell pellets were dissolved in 20 mM Tris–HCl (pH 7.2),
200 mM NaCl, 5% glycerol (w/w), and 5 mM 2-mercaptoethanol
and destroyed by sonication on ice. Then, the supernatant, including
numerous soluble proteins, was separated from the cell broth by
ultracentrifugation (17000 rpm, 30min). The cell pellets were resus-
pended and solubilized in 20 mM Tris–HCl (pH 8.0), 200 mM NaCl,
and 5 mM imidazole, including 6 M guanidine-HCl, for 5 h. After
resolubilization, the soluble fraction was collected using ultracentri-
fugation (14000 rpm, 25 min). Recombinant proteins were puriﬁed
using a Ni-NTA column (Amersham Biosciences), and the protein
was eluted in 20 mM Tris–HCl (pH 8.0), 200 mM NaCl, and 350 mM
imidazole, including 6 M guanidine-HCl, after column washing by
40 mM imidazole. The eluent was dialyzed in 1% acetonitrile and
0.01% triﬂuoroacetic acid (TFA) at room temperature for 12 h and
lyophilized overnight. The white powder was dissolved in Tris–HCl
(pH 7.6) and 200 mM urea and treated by thrombin enzyme
(molar ratio = 1:15) for 4 h at 37 °C. The N-terminal His-tags were
completely removed, and the ﬁnal step of peptide puriﬁcation was
performed using a peptide-grade Superdex 75 Gel Filtration Column
(Amersham Biosciences). The purity of the recombinant peptide was
conﬁrmed by MALDI-TOF Mass analysis. For the NMR experiments,
MC4RTM2 was labeled with 15NH4Cl and/or 13C-labeled glucose in
M9 media. MC4RTM2-D90N was generated by the quick mutagenesisscopy. (A) Primary sequence alignment and schematic diagram of seven helix domains of
ng them are conserved. Sequence alignment generated by ClustalW shows that the TM 2
was analyzed using CD (B) in different micelle conditions containing DPC, SDS, and TFE
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the same as those of MC4RTM2.
2.2. Cloning, insect cell culture, and puriﬁcation of MC4R and MC4RD90N
The ΔN5-MC4R-T4L-ΔC10 (MC4R) and ΔN5-MC4R-D90N-T4L-
ΔC10 (MC4RD90N) receptor constructs were ampliﬁed using a
codon-optimized synthetic gene (GenScript) as a template. The
gene was inserted into the pFastBac-33A, which modiﬁed the
pFastBac1 vector (Invitrogen) containing the hemagglutinin (HA)
signal sequence (KTIIALSYIFCLVFA) at the N-terminus with a
PreScission protease recognition sequence (LEVLFQG), a FLAG tag
(DYKDDDDK), and a 10x His tag at the C-terminus, using AscI
and FseI enzyme restriction sites. Generated constructs were
transformed to the DH10BacTM E. coli for transposition into the
bacmid. Bacmid DNA was isolated using the ethanol precipitation
method from inoculated white colonies. High-titer recombinant
baculovirus stocks (N108 plaque forming units (pfu) per ml) were
prepared using the Bac-to-Bac Baculovirus Expression System
(Invitrogen). Next, 3ug of recombinant bacmid DNA containing
the target gene were transfected into Spodoptera frugiperda (Sf9)
cells (0.5 × 106 cells/ml) using 8ul of Lipofectamine®2000 Reagent
(Life Technologies) and 100ul CCM3 media (HyCloneTM), and it
was incubated for 3 days at 27 °C. The P1 virus stock was isolated
by harvesting the supernatant after infection and used to generate
the high-titer baculovirus stock. The Sf9 cells (2 × 106 cells/ml)
were infected by the P3 virus at an optimal MOI (multiplicity of in-
fection, number of virus/number of cells) of 5 in Insectagro® media
(Corning) and incubated at 27 °C. Target protein-expressed cells
were harvested by centrifugation at 72 h post-infection and stored
at−80 °C.
Frozen cell pellets were thawed in a hypotonic buffer contain-
ing 10 mM HEPES (pH 7.5), 10 mM MgCl2, 20 mM KCl, and an
EDTA-free protease inhibitor cocktail (Roche), and the isolated
raw membrane was washed twice by dounce homogenization in
the same hypotonic buffer. Thereafter, it was washed in a high
osmotic buffer containing 10 mM HEPES (pH 7.5), 10 mM MgCl2,
20 mM KCl, and 1.0 M NaCl three times. The puriﬁed membranes
were resuspended in 10 mM HEPES (pH 7.5), 10 mM MgCl2,
20 mM KCl, and 40% glycerol; ﬂash-frozen in liquid nitrogen; and
stored at −80 °C.
For the solubilization of MC4R, puriﬁed membranes were thawed
on ice and preincubated with 500 μM antagonist SHU9119
(GenScript), 2.0 mg/ml iodoacetamide (Sigma), and an EDTA-free
protease inhibitor cocktail (Roche). After preincubation for 20 min
at 4 °C, membranes were solubilized in the presence of 800 mM
NaCl, 0.5% (w/v) n-dodecyl-β-D-maltopyranoside (DDM) (Anatrace),
and 0.1% (w/v) cholesteryl hemisuccinate (CHS) (Sigma) for 1.5 h at
4 °C. The solubilized fraction was isolated by ultracentrifugation at
150,000 × g for 40 min, and it was incubated with TALON IMAC resin
(Clontech) overnight. Then, the resin was washed with 50 mM HEPES
(pH 7.5), 800 mM NaCl, 10% (v/v) glycerol, 0.1% (w/v) DDM/0.02%
(w/v) CHS, 10 mM MgCl2, 8 mM ATP (Sigma), and 500 μM SHU9119
(GenScript). The second resin wash was done using 50 mM HEPES
(pH 7.5), 150 mM NaCl, 10% (v/v) glycerol, 40 mM imidazole,
0.05% (w/v) DDM/0.01% (w/v) CHS, and 500 μM SHU9119. The
MC4R was eluted with 50 mM HEPES (pH 7.5), 150 mM NaCl, 10%
(v/v) glycerol, 250 mM imidazole, 0.05% (w/v) DDM/0.01% (w/v)
CHS, and 500 μM SHU9119. The high-concentration imidazole was
removed using a PD-10 Desalting Column (GE Healthcare) before
the deglycosylation reaction. The PNGase enzyme was treated to
target protein and mixture was incubated with TALON IMAC resin
for 8 h. The second TALON resin work was performed, and the
MC4R protein was eluted in 50 mM HEPES (pH 7.5), 150 mM NaCl,
10% (v/v) glycerol, 250 mM imidazole, 0.05% (w/v) DDM/0.01%
(w/v) CHS, and 500 μM SHU9119. The puriﬁed MC4R in the presenceof SHU9119 was concentrated from ~0.2 mg/ml to 30 mg/ml with a
100-kDa molecular weight cut-off Vivaspin Concentrator (GE
Healthcare).
2.3. Analytical size-exclusion gel chromatography (aSEC)
The homogeneities of both MC4R andMC4RD90N proteins were con-
ﬁrmed for different NaCl concentrations from 0 mM to 500 mM. The
ACQUITY UPLC System (Waters) and BEH Column (Waters) were used
on 10 mM HEPES (pH 7.5), 10% glycerol, and 0.05% DDM/0.01% CHS
with 0 mM, 75 mM, 150 mM, 300 mM, and 500 mM NaCl gradients.
Six proteins, 400 kDa M.W. of Ferritin, 232 kDa M.W. of catalase,
158 kDa M.W. of aldolase, 43 kDa M.W. of ovalbumin, 20.4 kDa M.W.
of chymotrypsin A and 13.7 kDa M.W. of Ribonuclease A was used for
the standard curve ﬁt for the size calculation.
2.4. Thermostability assay
Both MC4R and MC4RD90N proteins were puriﬁed in the presence
of the antagonist SHU9119. N-[4-(7-diethylamino-4-methyl-3-
coumarinyl) phenyl] maleimide (CPM) dye (Invitrogen) was dis-
solved in dimethyl sulfoxide (DMSO) (Sigma) at 4 mg/ml and stored
at−80 °C. The CPM stock solution was then thawed and diluted 1:40
in dye dilution buffer (50 mM HEPES (pH 7.5), 150 mM NaCl, 10%
glycerol, 0.05% DDM/0.01% CHS). The receptor (3 μg) was diluted in
assay buffer (50 mM HEPES (pH 7.5), 150 mM NaCl, 10% glycerol,
0.05% DDM/0.01% CHS, 500 μM SHU9119) to a ﬁnal volume of
200 μL, and the thermal denaturation assay was performed in a
quartz ﬂuorometer cuvette (Starna Cells, Inc., Atascadero, CA). All
data were collected by a Cary Eclipse spectroﬂuorometer (Varian,
USA) with a temperature ramping rate at 1 °C/min. The excitation
wavelength was 387 nm, and the emission wavelength was 463 nm.
All assays were performed over a temperature range of 20–95 °C.
2.5. CD spectroscopy
All CD spectrawere recorded in 1 cmand 1mmpath length cylindri-
cal cells for peptides in various conditions using a JASCO-J-810 spectro-
polarimeter. Eight consecutive scans were accumulated and averaged.
The sample concentration was 50 μM, and micelle detergents were
added to the peptide solution in 20 mM sodium phosphate (pH 7.0).
CD spectra were detected with a 50 nm/min−1 scan speed, with a
190–250nmUV range for different pHvalues. Thepopulation of the sec-
ondary structures was estimated using the K2d server (http://www.
embl.de/~andrade/k2d/).
2.6. NMR spectroscopy and structure calculations
NMR experiments were performed using 2.5 mM 15N/13C-labeled
MC4RTM2 and MC4RTM2-D90N. Lyophilized protein sample was
dissolved in 20 mM sodium phosphate (pH 7.0), 40 mM DTT, 0.01%
sodium azide, 200 mM deuterium-labeled SDS, and 10% D2O. NMR
experiments were performed on Bruker DRX-500 and DRX-600
spectrometers in quadrature detection mode using a triple-
resonance probe equipped with an actively shielded pulsed ﬁeld
gradient (PFG) coil. All NMR data were collected at 303 K. Data were
processed usingNMRPipe/NMRDraw [27] or XWIN-NMR (Bruker Instru-
ments) software on a Silicon Graphics Indigo2 workstation and analyzed
using the Sparky 3.113 program [28]. Sequential resonance assignment
was executed by 1H–15N heteronuclear single quantum coherence [29]
and three-dimensional (3D) HNCACB, CBCACON and HBHACONH,
HCCH-total correlation spectroscopy (TOCSY) experiments [29–35].
Together with the assigned resonance chemical shift values and peak
intensity values obtained in 3D 15N-edited nuclear overhauser effect
spectroscopy (NOESY) (m = 150 ms) [36] and 13C-edited NOESY
(m = 150 ms) HSQC [37] spectra, the structure calculation was
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terwith 16 nodes. The phi and psi values obtained by the TALOS program
[39] were added during the CYANA program process as a structural
restraint. Sequential nuclear overhauser effects (NOEs) and typical
α-helix NOEs were detected in the NOESY spectra and were well
matched with the TALOS result. Around Gln97, Gly98, and Ser99,
not enough NOEs were detected due to dynamics nature and the
kink region of the MC4RTM2. Hydrogen bonds were determined
from the preliminary structures and amide proton exchange exper-
iment. A total of 233 unambiguous NOEs and 19 hydrogen bonds
were used for structure calculations. The ﬁnal reﬁned structures
were analyzed and visualized with PROCHECK [40], PyMOL [41],
and MOLMOL [42]. Reﬁnement of solution structure of MC4RTM2
was done by molecular dynamics simulations as previously reported
[43,44].
2.7. Molecular modeling
An atomic-resolution structure of MC4R was constructed using the
homology modeling method. The procedures of homology modeling,
which are optimized for GPCRs, can be divided into ﬁve steps: template
selection, alignment, model building, helix optimization, and loop
optimization. First, amino acid sequences of humanMC4Rwere obtain-
ed from the NCBI database (http://www.ncbi.nlm.nih.gov/), and a basic
local alignment search tool (BLAST) search was performed in the pro-
tein data bank (PDB) database to select the template. The B2 adrenergic
receptor (B2AR, PDB ID: 2RH1) showed the nineteen percent of se-
quence identities with MC4R in the BLAST results, so we chose B2AR
as the template and performed manual sequence alignment between
B2AR and MC4R on the basis of the positions of GPCR conserved motifs
in each TM. Subsequently, the constructed helix and loop parts of MC4R
were separated based on the template. Seven helices were built using
the template-structure-based approach with the Prime [45] homology
modeling tool of Schrödinger suites, and six extra- and intra-cellular
loops were created using the de novo loop creation tool in BioLuminate
[46], also of Schrödinger suites. The helix and loop parts were built sep-
arately, as GPCR loop structures are as diverse in their lengths, shapes,
and amino acid compositions as the species, whereas helix structures
are rather constant across different species. As a result, there is no ro-
bust template to use for loop-structure building, and thus, the loop
structures were built using the energy-based approach. Optimizations
were also processed separately. First, we reﬁned the side-chain confor-
mations of helix regionsusing Prime's side-chain reﬁnement tool. In this
step, the implicit membrane was imposed on the helix regions for the
precise reﬁnement of the exterior side chains. Next, we performed sim-
ulated annealing dynamics to ﬁnd the globally optimized conformation
of the loops using Desmond [47]. The simulation was run for 20 ns at
100–400 K, and the POPC (1-palmitoyl-2-oleoyl-sn-glycero-3-
phosphocholine) explicit membrane was assumed in the helix regions,
which were ﬁxed by force constraints. Before the simulation, we put a
sodium atom similar to that of the A2A adenosine receptor crystal
structure [48] in the sodium allosteric binding site and placed water
molecules around it.
3. Results
3.1. Expression and puriﬁcation of MC4RTM2
MC4RTM2 was identiﬁed by BLAST search and sequence align-
ment. The primary sequence alignment showed that the TM 2
domain of MC4R was well conserved among human MCR families
(Fig. 1A). MC4RTM2 and MC4RTM2-D90N were successfully inserted in
the pET21b vector, and it was expressed in the E. coli system. To ob-
tain uniformly 13C- and 15N-labeled MC4RTM2 and MC4RTM2-D90N for
structural studies, M9 minimal media was used for bacterial culture.
The ﬁnal peptide yield was approximately 15mg according to 500mlcell culture, and peptide purity was over 90% according to MALDI-TOF
Mass analysis.
3.2. Structural analysis by CD spectroscopy
CD spectra were acquired on MC4RTM2 under DPC, SDS micelle, TFE
and different pH conditions. To determine optimal micelle conditions,
all CD spectra were measured in the same peptide concentration of
50 μM in 20 mM sodium phosphate (pH 7.0) but with different micelle
detergents. Data showed that MC4RTM2 contained a low helical content
of about 28% and 39% in H2O and 200 mM dodecylphosphocholine
(DPC) micelle conditions, respectively. However, the characteristic
α-helical populations were observed for MC4RTM2 in both 50 mM
SDS and 50% tetraﬂuoroethylene (TFE) solution (Fig. 1B): a typical
double minima of transition (n-π*) at 208 and 222 nm and a maximum
of transition (π-π*) at 192 nm. Around eighty-four percent of helical
contents were observe in both the 50 mM SDS and 50% TFE conditions
(Fig. 1B). However, there were no signiﬁcant structural changes for
different pH values (Fig. 1C). Data from the CD spectrum suggest that
MC4RTM2 forms anα-helical structure in the presence of an SDSmicelle
environment.
3.3. NMR resonance assignments
A series of 1H–15N 2D HSQC spectra were collected for different de-
tergent conditions (TFE, DPC, SDS) (data was not shown). MC4RTM2
showed the maximum helical population and homogeneity at the
200 mM SDS micelle condition. The NMR experimental condition was
optimized by a series of 1H–15N 2DHSQC spectra for different pH condi-
tions. The NMR spectra at 200mM SDS and pH 7.0 showed that most of
theNH/CαH resonanceswerewell separated, indicating homogeneity of
the MC4RTM2 conformation (Fig. 2A).
Both backbone and side-chain assignments were done by following
the correlation of the NH group to the preceding Cα and Cβ chemical
shifts, and the side-chain proton resonances were easily identiﬁed by
HCCH-TOCSY connectivity (Fig. 2A). Backbone assignment was
completely assigned and 90% of carbon and 95% of proton of sidechain
atom were assigned. The secondary structures of MC4RTM2 were con-
ﬁrmed by following dαN (i, i + 1), dNN (i, i + 1) NOE connectivities in
the NOESY spectrum [49] (Fig. 2B) with both the TALOS and CSI (chem-
ical shift index) programs. NMR data suggested that MC4RTM2 forms a
long α-helix with a kink at Gly98. The long α-helix is composed of
two regions from Met79 to Asn97 and Gln100 to Thr105 (Fig. 2B).
3.4. Solution NMR structure of MC4RTM2
The 20 energy-minimized NMR structures of MC4RTM2 were
calculated from the 100 initial structures. The average target function
value was 0.251 ± 0.0181. No violations for distance constraints were
detected during structure calculation. Themean rootmean square devi-
ation (RMSD) values of backbone atoms and all heavy atoms fromTyr80
to Asn97 were 0.671 ± 0.05 and 0.793± 0.03, respectively (Fig. 3A). In
addition, themeanRMSDvalues of backbone atoms and all heavy atoms
fromThr101 to Leu106were 0.566±0.03 and 0.623±0.01, respective-
ly (Fig. 3B). The phi–psi dihedral angles of the ﬁnal structures were
appropriately distributed in the Ramachandran plot. The values were
86.8%, and 13.2%, in most favored and additionally allowed regions,
respectively. After the structural reﬁnement via molecular dynamics
simulation methods, overall structure of MC4RTM2 was stabilized after
1 ns and average RMSD of heave atomswas 2.3566. The ribbon drawing
of the MC4RTM2 structure with all side-chain atoms provides a clear
picture of the kink at the end of the helix (Fig. 3C). Structure statistics
and structure quality factors are shown in Table 1. Helix bending in
the TM2 of the GPCRs is observed and it may allow the structural diver-
sity within the GPCR family [50]. To understand common structural
properties of TM2 in GPCRs, we superimposed solution structure of
Fig. 2. Backbone assignment and NOE bar diagram of MC4RTM2. (A) 1H–15N HSQC spectra of MC4RTM2 were collected in 20 mM sodium phosphate (pH 7.0), 40 mM DTT, 0.01%
sodium azide, 200 mM deuterium-labeled SDS, and 10% D2O at 303 K. All resonances were assigned using triple resonance NMR data. Asterisks (*) indicate extra residues from
the KSI tag (GC1GKKKKC6). (B) A summary of NOEs indicates theα-helical structure of MC4RTM2. The thickness of NOEs shows the NOE cross-peak intensity. The secondary structure of
MC4RTM2 was conﬁrmed by the CSI (ﬁlled squares) and TALOS (ﬁlled circles) programs using experimental data.
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B2 adrenergic receptor (Fig. 3D).3.5. Structural comparison between MC4RTM2 and MC4RTM2-D90N
To observe the structural difference between MC4RTM2 and
MC4RTM2-D90N, the MC4RTM2-D90N peptide was prepared in the
same way as MC4RTM2. The backbone resonance assignments of
MC4RTM2-D90N were completed using data from HNCACB and HNCA
(Fig. 4A). The amide-proton chemical shift of MC4RTM2-D90N was
very similar to and overlapped well with that of MC4RTM2. The
substitution from Asp90 to Asn90 was directly conﬁrmed by the
backbone resonance assignments (Fig. 4A). Using the Cα and Cβ
chemical shift values, the phi–psi dihedral angles were calculated
with the TALOS program. The secondary structure of MC4RTM2-D90N
predicted by CSI was the same as that of MC4RTM2 (Fig. 4B). Similarly,Fig. 3. Solution structures of MC4RTM2. The 20 structures of MC4RTM2 over the energy-minimize
(B) Asn97-Leu106 in stereoview, respectively. (C) The average structure ofMC4RTM2 is represen
the structural dynamics region between two helices are indicated by an arrow. The image was g
receptors based on sequence alignment have shown similar kink shape in TM2, although the pat
and B2 adrenergic receptor are colored by blue, cyan and yellow, respectively.data from CD conﬁrmed that MC4RTM2-D90N forms an α-helix in SDS
micelle conditions (Fig. 4C).3.6. Thermal stability and homogeneity of MC4R and MC4RD90N
The thermal stability and homogeneity of MC4R and MC4RD90N
were measured by aSEC and CPM ﬂuorescence spectroscopy assay
in 50 mM HEPES (pH 7.5), 150 mM NaCl, 0.05% DDM/0.01% CHS,
10% glycerol, and 500 μM SHU9119. Data from aSEC showed that
structural homogeneity was changed by point mutation at Asp90.
MC4RD90N was less stable thanMC4R (Fig. 5A). The CPM ﬂuorescence
spectroscopy based on the binding of the thiol-speciﬁc maleimide
CPM to cysteines showed that the melting curves of both MC4R and
MC4RD90N had clear transitions at 60 °C and 56 °C, respectively
(Fig. 5B). The thermal stability result indicated that mutation led
MC4RD90N to become unstable.d average structure (generated byMOLMOL) are superimposed for (A)Met 79-Asn97 and
ted by a ribbon diagram, and the side chains are colored in yellow. Three residues located in
enerated by PyMOL. (D) The Structural superimposition of TM2 region among three GPCR
terns anddegree of kink region are different. The TM2 fromMC4R, A2A adenosine receptor
Table 1
Structural statistics and mean squared deviations (RMSD) for the 20 lowest-energy struc-
ture of MC4R TM277–106.
Experiment distance constraints MC4R TM277–106
NOE distance constraints
Total 233
Sequential, |i–j| = 1 87
Short-range, |i–j| ≤ 1 161
Medium range, 1 b |i–j| b 5 72
Intra-residue, |i–j| = 0 74





Mean CYANA target function (Å2) 0.231 ± 0.028
Number of restraint violations
Total number of distance violations N0.5 Å 0
Total number of hydrogen bond violation N0.5 Å 0
Total number of dihedral angle violations N5 0
Mean RMS deviations from the average coordinate (Å)a
Backbone atoms of residues (80–97) 0.671 ± 0.05
Heavy atoms (80–97) 0.793 ± 0.03
Backbone atoms of residues (101–106) 0.566 ± 0.03
Heavy atoms (101–106) 0.623 ± 0.01
Ramachandran plot (%)a
Residues in most favored regions 86.8
Residues in additional allowed regions 13.2
Residues in generously allowed regions 0.0
Residues in disallowed regions 0.0
a Ramachandran plot was calculated using the PROCHECK program.
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To understand the effect of sodium ion on MC4R and MC4RD90N, we
performed aSEC in different salt concentration (0mM–500mM).While
uniform conformational states of MC4R were observed for different salt
concentrations (Fig. 6A), inhomogeneous states were detected for
MC4RD90N (Fig. 6B). According to column calibration, retention time of
5.6 min demonstrates dimeric size of MC4R (119.4 kDa) while 5.9 min
is the monomeric size (62 kDa). Since GPCR function is related to not
only conformational change but oligomerization status, we investigatedFig. 4. Backbone assignment and secondary structures of MC4RTM2-D90N. (A) 1H–15N HSQC spe
0.01% sodium azide, 200 mM deuterium-labeled SDS, and 10% D2O at 303 K. All peaks were co
KSI tag (GC1GKKKKC6). (B) Phi and psi torsion angles of MC4RTM2-D90N (Φ — open circle and
that of MC4RTM2 (Φ — open triangle and Ψ — ﬁlled triangle colored in red). The psi and phi
SDS micelles. (C) The secondary structures of both MC4RTM2 (ﬁlled circle) and MC4RTM2-D
(pH 7.0), 50 mM SDS.the structural integrity of both MC4R and MC4RD90N for different salt
concentrations. Our data suggests that salt concentration plays a role
for oligomerization process of MC4R. MC4RD90N fails salt-mediated
oligomerization process, resulting loss of its function. Therefore, we
concluded that Asp902.50 residue plays an important role in both the
stability and homogeneity of MC4R upon sodium binding.
3.8. Sodium ion binding site of MC4R
In general, seven TMs in GPCR structure have extensive hydrogen
bond network and they interact with water and sodium ion in direct
or indirect manner. Recent studies have shown that the interaction
between water and sodium ion is important for GPCR function. Our
data suggest that the hydrogen bond network and sodium ion interac-
tion are highly related in GPCR function. Data from the temperature
coefﬁcients of the amide protons of MC4RTM2 represented that both
Leu86 and Asp90 showed relatively high temperature coefﬁcients in
the sodium-binding pocket (Fig. 6C). Therefore, we propose the struc-
tural clue for the sodium ion binding during conformationalmodulation
of MC4R [51,52]. The modeling structure of MC4R in the presence of
sodium ions based on the crystal structure of B2AR demonstrated that
both sodium ions and water molecules were co-oriented to conserve
the allosteric pocket (Fig. 7A). The modeling structure of MC4R
suggested that sodium ions coordinated the conserved residues of
MC4R in the allosteric sodium-binding pocket together with several
water molecules. The distance between sodium ion and water
molecules was measured as 2–3 Å. Asp902.50, Ser1363.39, and
Asp2947.49 residues largely participated in sodium ion binding
(Fig. 7B). The superimposed structures of A2AAR, B2AR, and CXCR4
with MC4R support this hypothesis, showing that the residues in the
allosteric sodium ion binding pocket of Class A GPCRs were well
conserved (Fig. 7C and D).
4. Discussion
In this study, we presented the structural role of Asp902.50 of MC4R
as a key residue in the sodium ion allosteric pocket. Recent GPCR studies
suggest that the Asp2.50 residue in the TM2 domain of GPCRs is involved
in structural and functional diverse by interactionwith theNPxxYmotif.ctra of MC4RTM2-D90N were collected in 20 mM sodium phosphate (pH 7.0), 40 mM DTT,
mpletely assigned using backbone datasets. Asterisks (*) indicate extra residues from the
Ψ — ﬁlled circle colored in black) obtained from the TALOS program are compared with
angle values suggest that both MC4RTM2 and MC4RTM2-D90N have α-helical structures in
90N (open circle) were analyzed using CD spectroscopy in 20 mM sodium phosphate
Fig. 5.Measurement of conformational homogeneity and thermal stability of MC4R and MC4RD90N. (A) The conformational homogeneity of MC4R (ﬁlled circle) and MC4RD90N (empty
circle) wasmeasured by aSEC traces. (B) The thermal stability of MC4R (ﬁlled circle) and MC4RD90N (empty circle) wasmeasured. Melting temperatures (Tm) were determined by ﬁtting
the curves to a Boltzmann sigmoidal equation and were as follows: MC4R, Tm = 60 °C; MC4RD90N, Tm = 56 °C.
1300 J.-H. Yun et al. / Biochimica et Biophysica Acta 1848 (2015) 1294–1302In the same manner, the Asn7.49 residue in the NPxxY motif is also
involved in the sodium ion allosteric pocket and plays the role of a
switch for both the active and inactive conformation of GPCRs [53,54].
In addition, recent papers proposed that when distances between
Asn3227.49 in the NPxxY motif and Asp792.50 of B2AR in the agonist, in-
verse agonist, and Apo states were measured, the distance between
Asn3227.49 and Asp792.50 was small in the active state. In contrast, the
distance between Asn3227.49 and Asp792.50 was large in the inactive
state by the side-chain orientation of Asn3227.49, indicating that theFig. 6. Salt effect onMC4R andMC4RD90N and temperature coefﬁcient experiment forMC4RTM2.
(colored in red), 150 mM (colored in blue), 300mM (colored in yellow), and 500 mM (colored
(B) aSEC traces of MC4RD90N with ﬁve different salt conditions (0 mM (colored in black), 75 m
(colored in green)) were shown. Retention time was shifted by increasing salt concentration
20 mM sodium phosphate (pH 7.0), 40 mM DTT, 0.01% sodium azide, 200 mM deuterium-lab
obtained by linear ﬁtting of the amide chemical shift (δHN) as a function of temperature measu
residue is proline and, the others, because of poor signal sensitivity of signal to noise, we cou
are labeled as ⊙.inter-helical space becomes wider to provide enough space for sodium
ion interaction [26,55].
However, although MC4R has a conserved sodium ion allosteric
pocket similar to other Class A GPCR family proteins, Asp902.50 interacts
with Asn2947.49, which is not located in the NPxxYmotif. Because of the
conserved motif of the NPxxY substitute to DPxxY in MC4R, the signal-
ing mechanism of MC4R would differ from that of other Class A GPCR
family proteins. For example, the opsin receptor in the active state has
a hydrogen-bond interaction between Asn3027.49 and Tyr306 in the(A) aSEC traces ofMC4Rwithﬁvedifferent salt conditions (0mM(colored in black), 75mM
in green)) were represented. Retention time was shifted by increasing salt concentration.
M (colored in red), 150 mM (colored in blue), 300 mM (colored in yellow), and 500 mM
. (C) Temperature coefﬁcients (Δδ/ΔT) of amide protons of MC4RTM2 were measured in
eled SDS, and 10% D2O at ﬁve different temperatures. The temperature coefﬁcients were
red at 25 °C (cyan), 30 °C (red), 35 °C (yellow), 40 °C (magenta), and 45 °C (green). One
ld not conﬁrmed those peaks during temperature coefﬁcient test. The undetected peaks
Fig. 7.Modeling structure of MC4R and structural insight of conserved sodium ion allosteric pocket. (A) A 3D structure of MC4Rwith sodium ions was generated by homologymodeling.
(B) Allosteric sodium ion binding pocket of MC4R with water molecules (red sphere) and sodium ions (blue sphere) were displayed. Water molecules surround sodium ions, stabilizing
Helices 2, 3, and 7. (C) Side-chain orientations of residues in sodium ion allosteric pocket of MC4R were looked in detail. Asn90 is a key residue for sodium ion interaction. (D) Structural
comparison between MC4R and A2AAR displays intermolecular interaction between sodium ions (blue and violet sphere for MC4R and A2AAR) and water molecules (red and green
sphere for MC4R and A2AAR).
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Asp298 (DPxxY) interacts with Asn2947.49 instead [56]. The mutational
study of 5-HT2A, including the NPxxY and DPxxY motifs, already proves
that the molecular selectivity with interacting proteins, such as ARF1
and ARF6, was shifted in Asn (N)/Asp (D) substitution [57]. Further-
more, in many cases of other GPCRs, it has been proposed that sodium
ions bind in an allosteric site (Asp2.50) located in the TM 2 domain and
act as allosteric modulators [58–60]. The high-resolution X-ray crystal
structure of A2AAR coordinated with the sodium ion and conserved
water molecules in the center of the seven TM bundles clearly supports
the vital role of sodium ions in GPCR functions [48]. Therefore, Asp902.50
located in the sodium ion allosteric binding pocket plays a key role in
not only mediating allosteric regulation by sodium ion interaction but
also enabling the switch between active and inactive conformation
through NPxxY motif interaction.
In our study, the NMR structure of MC4RTM2 revealed an α-helix
conformation with a kink similar to that of solved GPCR structures.
The helical bend in the TM 2 domain is not unusual, and it is partially re-
sponsible for multilithic TM functions [24]. Interestingly, we found that
the temperature coefﬁcients of four residues such as Ser85, Leu86,
Asp90, and Glu100 were relatively large, as shown in Fig. 6C. This is
also explainable in terms of the dynamic nature of the TM 2 domain.
Data fromNMR and CD spectroscopy show that the secondary structure
of MC4RTM2-D90N is not affected by substitution from Asp90 to Asn90.
However, the stability and homogeneity of MC4R are dramatically
changed upon point mutation due to the different interaction modes
with sodium ions and the DPxxY motif. Our data strongly suggest a
dominant negative effect of theheterozygousMC4Rmutant. In addition,
although MC4R has a tendency to maintain a single conformation for
different sodium ion concentrations, MC4RD90N does not have a stable
conformation, meaning that the mutant protein cannot form either
the active or the inactive saturated state. Our results suggest that
MC4R is necessary to ensure the optimum efﬁcacy of sodium ions and
maintain the stable dimer or oligomer formation of MC4R in a functionand that the TM 2 domain plays a role as the pivot of conformational
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